Skip to main content
This profile is being populated. Some content may not yet be available. See Medicine for additional information.

Publications

2 publications

Funding

1 grant
Completed grants (1)
  • Sub-PI
    Real world experience on the use of ceftolozane-tazobactam in the treatment of Gram-negative bacteremia - a multicentric experience from the United States
    Merck Sharp & Dohme LLC · 2022–2025 · via University of Florida
    UF 232202-01

Clinical research

1 study
Completed & closed trials (1)
  • PI
    SPIND 173509 Clofazimine
    Novartis Pharmaceuticals Corporation · CLOSED TO ACCRUAL (as of 2024)